Viatris (VTRS) Common Equity (2019 - 2026)
Viatris (VTRS) posted quarterly Common Equity of $14.7 billion for Q1 2026, down 6.34% year-over-year from $15.7 billion in Q1 2025, and little changed quarter-over-quarter from $14.7 billion in Q4 2025.
Viatris (VTRS) Common Equity (2019 - 2026) Analysis & Trends
Viatris' Common Equity history runs 8 years deep, the most recent figure standing at $14.7 billion for Q1 2026.
- In Q1 2026, Common Equity fell 6.34% year-over-year to $14.7 billion; the TTM figure through Mar 2026 stood at $14.7 billion (down 6.34% YoY), while the FY2025 annual figure was $14.7 billion, down 21.06% from the prior year.
- Common Equity for Q1 2026 stood at $14.7 billion, roughly flat from $14.7 billion in the prior quarter.
- The five-year high for Common Equity was $21.1 billion in Q4 2022, with the low at $14.7 billion in Q1 2026.
- The 5-year median for Common Equity is $19.8 billion (2024), against an average of $18.7 billion.
- The sharpest annual moves came in 2023 and 2025: Common Equity advanced 8.78% in 2023, then declined 23.11% in 2025.
- Viatris' Common Equity stood at $21.1 billion in 2022, then fell by 2.87% to $20.5 billion in 2023, then declined by 8.95% to $18.6 billion in 2024, then decreased by 21.06% to $14.7 billion in 2025, then declined by 0.36% to $14.7 billion in 2026.
- Business Quant data shows VTRS's Common Equity at $14.7 billion in Q1 2026, $14.7 billion in Q4 2025, and $15.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.26 Bn |
| Mar 31, 2026 | 14.66 Bn |
| Dec 31, 2025 | 14.71 Bn |
| Sep 30, 2025 | 15.22 Bn |
| Jun 30, 2025 | 15.57 Bn |
| Mar 31, 2025 | 15.65 Bn |
| Dec 31, 2024 | 18.64 Bn |
| Sep 30, 2024 | 19.79 Bn |
| Jun 30, 2024 | 19.52 Bn |
| Mar 31, 2024 | 20.01 Bn |
| Dec 31, 2023 | 20.47 Bn |
| Sep 30, 2023 | 20.87 Bn |
| Jun 30, 2023 | 20.84 Bn |
| Mar 31, 2023 | 20.93 Bn |
| Dec 31, 2022 | 21.07 Bn |
| Sep 30, 2022 | 19.18 Bn |
| Jun 30, 2022 | 19.81 Bn |
| Mar 31, 2022 | 20.45 Bn |
| Dec 31, 2021 | 20.49 Bn |
| Sep 30, 2021 | 21.14 Bn |